Purdue Pharma L.P. et al v. Mylan Pharmaceuticals Inc. et al
||Purdue Pharma L.P., Purdue Pharmaceuticals L.P., The P.F. Laboratories, Inc. and Rhodes Technologies
||Mylan Pharmaceuticals Inc. and Mylan, Inc.
||December 16, 2015
||US District Court for the District of Delaware
||Sue L. Robinson
|Nature of Suit:
|Cause of Action:
||35 U.S.C. § 271
|Jury Demanded By:
Access additional case information on PACER
Available Case Documents
The following documents for this case are available for you to view or download:
|June 13, 2017
MEMORANDUM ORDER: The Report and Recommendation (D.I. 67 ) is ADOPTED. The Motion to Dismiss (D.I. 23 ) is DENIED. Signed by Judge Richard G. Andrews on 6/13/2017. (nms)
|March 1, 2017
REPORT AND RECOMMENDATIONS re 23 MOTION to Dismiss Based upon Pursuant to Fed. R. Civ. P. 12(b)(6) filed by Mylan, Inc., Mylan Pharmaceuticals Inc. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefi ng consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 3/20/2017. Signed by Judge Sherry R. Fallon on 3/1/17. (cak)
Use the links below to access additional information about this case on the US Court's PACER system.
A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?